Protia Inc. designs, develops, and sells diagnostic kits in South Korea. The company offers PROTIA Allergy-Q, an assay kit for quantitative determination of specific IgE antibodies against individual allergens in human serum using immunoblotting technique; ImmuneCheck IgG, a whole blood test kit for total IgG concentration measurement; and TriCheck-C, an in vitro diagnostic kit for the qualitative test of human chorionic gonadotropin in human urine samples for the pregnancy diagnosis. It also provides protia food iga, a chronic food intolerance test to identify the foods that do not fit, and stay healthy; anitia canine ige, a serum to identify the cause of the allergy; anicheck bovine igg, a colostrum for feeding calves. In addition, the company provides genedania, a kit for the detection of nucleic acid from SARS-CoV-2. Further, it offers 2-D electrophoresis, mass spectrometry, post translational, and protein services. The company was formerly known as ProteomeTech Inc. and changed its name to Protia Inc. in November 2023. Protia Inc. was founded in 2000 and is based in Seoul, South Korea.
South Korean Market Performance
7D7 Days: 1.7%
3M3 Months: 24.3%
1Y1 Year: 14.7%
YTDYear to Date: 31.9%
The market is up 1.7% over the last week, with the Industrials sector leading the way, up 5.0%. Meanwhile, the Financials sector has underperformed, shrinking 3.2% in that time. The market is up 15% over the last 12 months. Earnings are forecast to grow by 21% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...